US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VictoryShares US 500 Enhanced Volatility Wtd ETF

76.24

+0.23780.31%

Volume:8.38K

Turnover:631.94K

Market Cap:407.87M

PE:381.19

High:76.36

Open:75.09

Low:74.65

Close:76.00

52wk High:78.74

52wk Low:60.03

Shares:5.35M

Float Shares:5.35M

Volume Ratio:1.72

T/O Rate:0.16%

Dividend:0.97

Dividend Rate:1.28%

EPS(TTM):0.2000

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

French Satellite Operator Eutelsat Appoints Imerys Executive as Next CFO

Rapid7 Announces Third Quarter 2025 Financial Results

Press Release: Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development

K Wave Media Appoints Yong Fang as Chief Financial Officer

Press Release: Bank of the James Announces CFO--CIO Transition and Appointment of New Chief Financial Officer

Fiserv Cuts Annual Profit Forecast, Shares Plunge 27%

Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

Elon Musk Loses Another Top Executive As X's Ad Chief Reportedly Quits

Benzinga_recent_news

Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress

Press Release: I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer

Press Release: Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer

Switzer Investing TV | 13 Oct 2025: Super Tax changes incoming | Trump v China, Part II | Busting Australian property myths

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

Cornish Metals Announces Exercise of Stock Options and Issue of Equity & PDMR Dealings

Press Release: CompoSecure Appoints Mary Holt as Chief Financial Officer

PepsiCo Reports Strong Third Quarter Revenue Despite Weakening North American Demand

What's Behind AlphaTON Capital's 123% After-Hours Spike?

Why Planet Labs Stock Is Skyrocketing This Week

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CFO/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CFO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CFO\",,,,,undefined,":{"symbol":"CFO","market":"US","secType":"STK","nameCN":"VictoryShares US 500 Enhanced Volatility Wtd ETF","latestPrice":76.2374,"timestamp":1773086400000,"preClose":75.9996,"halted":0,"volume":8383,"delay":0,"changeRate":0.0031289638366516783,"floatShares":5350000,"shares":5350000,"eps":0.2,"marketStatus":"Pre-Mkt","change":0.2378,"latestTime":"03-10 04:14:35 EDT","open":75.09,"high":76.36,"low":74.65,"amount":631942.1055,"amplitude":0.0225,"askPrice":79.55,"askSize":66,"bidPrice":64.66,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0.2,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773149400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":76.1159,"sharesOutstanding":5350000,"nav":76.009625,"aum":406651360,"dividendRate":0.01276,"bidAskSpread":0.000899,"postHourTrading":{"tag":"盘后","latestPrice":76.12,"preClose":76.2374,"latestTime":"16:10 EDT","volume":7,"amount":533.6618,"timestamp":1773087004405,"change":-0.1174,"changeRate":-0.00154,"amplitude":0},"volumeRatio":1.715578,"impliedVol":0.1087,"impliedVolPercentile":0.896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CFO\",,,,,undefined,":{"symbol":"CFO","floatShares":5350000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.715578,"shares":5350000,"dividePrice":0.9728,"high":76.36,"amplitude":0.0225,"preClose":75.9996,"low":74.65,"week52Low":60.03,"pbRate":"--","week52High":78.735,"institutionHeld":0,"latestPrice":76.2374,"committee":0.204819,"eps":0.2,"divideRate":0.01276,"volume":8383,"delay":0,"ttmEps":0.2,"open":75.09,"prevYearClose":73.8438,"prevWeekClose":75.9996,"prevMonthClose":78.4089,"prevQuarterClose":73.8438,"fiveDayClose":78.5231,"twentyDayClose":77.7199,"sixtyDayClose":73.2352},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CFO\",params:#limit:5,,,undefined,":[{"date":"2026-02-09","symbol":"CFO","amount":0.041108,"announcedDate":"2026-02-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-09","defaultRemindTime":1770647400000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-10","payableDate":"2026-02-09","currency":"USD","dateTimestamp":1770613200000,"payDate":"2026-02-10"},{"date":"2026-01-08","symbol":"CFO","amount":0.111805,"announcedDate":"2026-01-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-08","defaultRemindTime":1767882600000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-09","payableDate":"2026-01-08","currency":"USD","dateTimestamp":1767848400000,"payDate":"2026-01-09"},{"date":"2025-12-11","symbol":"CFO","amount":0.110156,"announcedDate":"2025-12-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-11","defaultRemindTime":1765463400000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-12","payableDate":"2025-12-11","currency":"USD","dateTimestamp":1765429200000,"payDate":"2025-12-12"},{"date":"2025-11-07","symbol":"CFO","amount":0.035223,"announcedDate":"2025-11-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-07","defaultRemindTime":1762525800000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-10","payableDate":"2025-11-07","currency":"USD","dateTimestamp":1762491600000,"payDate":"2025-11-10"},{"date":"2025-10-09","symbol":"CFO","amount":0.085409,"announcedDate":"2025-10-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-09","defaultRemindTime":1760016600000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-10","payableDate":"2025-10-09","currency":"USD","dateTimestamp":1759982400000,"payDate":"2025-10-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CFO\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-17","value":0.1457861,"currency":"USD"},{"executeDate":"2016-09-07","recordDate":"2016-09-09","paymentDate":"2016-09-12","value":0.1089324,"currency":"USD"},{"executeDate":"2016-11-15","recordDate":"2016-11-17","paymentDate":"2016-11-18","value":0.086566,"currency":"USD"},{"executeDate":"2016-12-13","recordDate":"2016-12-15","paymentDate":"2016-12-16","value":0.0834409,"currency":"USD"},{"executeDate":"2017-01-17","recordDate":"2017-01-19","paymentDate":"2017-01-20","value":0.020249,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CFO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CFO\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133440699","title":"French Satellite Operator Eutelsat Appoints Imerys Executive as Next CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=1133440699","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133440699?lang=en_us&edition=fundamental","pubTime":"2025-11-05 17:00","pubTimestamp":1762333218,"startTime":"0","endTime":"0","summary":"French satellite operator Eutelsat announced on Wednesday that it has appointed Sébastien Rouge as its new Chief Financial Officer (CFO).   Rouge currently serves as the financial head of mineral...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO"],"gpt_icon":0},{"id":"2581696417","title":"Rapid7 Announces Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581696417","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581696417?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:01","pubTimestamp":1762290060,"startTime":"0","endTime":"0","summary":"Annualized recurring revenue (“ARR”) of $838 million, an increase of 2% year-over-yearTotal revenue of $218 million, up 2% year-over-year; Product subscriptions revenue of $210 million, up 2% year-ove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180808/36514/en/Rapid7-Announces-Third-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO","RPD","BK4097","LU1878469433.USD"],"gpt_icon":0},{"id":"2580758164","title":"Press Release: Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2580758164","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580758164?lang=en_us&edition=fundamental","pubTime":"2025-11-04 22:30","pubTimestamp":1762266600,"startTime":"0","endTime":"0","summary":"TORONTO, Nov. 4, 2025 /PRNewswire/ -- At 10:00 a.m.  on November 3, 2025, Visionary Holdings Inc.  successfully convened the First Meeting of the Fourth Board of Directors. In strict compliance with the Business Corporations Act , Securities Exchange Act of 1934 , NASDAQ Listing Rules, and the relevant provisions of the Company's Bylaws, the meeting was conducted with legitimate convening procedures, qualified participants, and rigorous voting rules. All directors attended the meeting and unanimously adopted all core proposals, with the resolutions being legally valid, laying a solid institutional foundation for the Company's stable operations in the next phase.As a significant milestone in the Company's development, the meeting completed key deployments for optimizing the governance structure and forming the core team, establishing a professional and efficient collaborative governance ecosystem:","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","BK4120","LU2272731782.SGD","USA","BK4204","BK4588","LU2272731600.USD","TSYW.SI","PSQ","BK4198","LU1992135399.USD","USAW.SI","USJW.SI","GB00BDT5M118.USD","SQQQ","GV","CFO","BK4585",".IXIC","MNQmain","QLD","LU2211815571.USD","CEO","TISI","QID","LU1992135472.HKD","TQQQ","COO"],"gpt_icon":1},{"id":"2580734116","title":"K Wave Media Appoints Yong Fang as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2580734116","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580734116?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:12","pubTimestamp":1762261920,"startTime":"0","endTime":"0","summary":"NEW YORK and SEOUL, Nov.  04, 2025  (GLOBE NEWSWIRE) -- K Wave Media (Nasdaq: KWM), a Korean cultural innovation and digital asset company, today announced the appointment of Yong (Howard) Fang as its","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180318/0/en/K-Wave-Media-Appoints-Yong-Fang-as-Chief-Financial-Officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4120","LU0240877869.USD","TTTN","LU0205194284.USD","RTO","IE0009354923.USD","LU0240878834.USD","CFO","IPO","LU0205193047.USD"],"gpt_icon":0},{"id":"2579273177","title":"Press Release: Bank of the James Announces CFO--CIO Transition and Appointment of New Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2579273177","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579273177?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:30","pubTimestamp":1761856200,"startTime":"0","endTime":"0","summary":"LYNCHBURG, Va., Oct. 30, 2025  -- Bank of the James Financial Group, Inc.  , the parent company of Bank of the James , a full-service commercial and retail bank, and Pettyjohn, Wood & White, Inc. , an SEC-registered investment advisor, today announced changes to the Bank's executive leadership to improve oversight and better coordinate financial and investment approaches.-- J. Todd Scruggs, currently serving as Chief Financial Officer, will. transition to the new role of Chief Investment Officer .-- Eric J. Sorenson, Jr., who has served as General Counsel for more than. three years and has advised the Bank and the Company on regulatory, legal,and financial matters for over 25 years, will be appointed as Chief. Mr. Sorenson has served as Executive Vice President - General Counsel of the Bank since 2022, guiding the Ban","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO","BK4211","BK4223","BK4194","BOTJ","CIO"],"gpt_icon":0},{"id":"1115399854","title":"Fiserv Cuts Annual Profit Forecast, Shares Plunge 27%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115399854","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115399854?lang=en_us&edition=fundamental","pubTime":"2025-10-29 20:03","pubTimestamp":1761739426,"startTime":"0","endTime":"0","summary":"Focus: Q3 2025 U.S. Earnings Season   Payment services provider Fiserv slashed its annual profit forecast for the second consecutive quarter on Wednesday and announced a sweeping leadership overhaul...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"433e4251d16de9467ab458a4dee34040","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO","CEO"],"gpt_icon":0},{"id":"2579977634","title":"Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2579977634","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579977634?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:00","pubTimestamp":1761735600,"startTime":"0","endTime":"0","summary":"Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major Multinational","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/29/3176253/23089/en/Lifecore-Biomedical-Selected-as-New-Commercial-Manufacturing-Partner-by-Leading-Global-Pharmaceutical-Company.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDMO","BK4121","BK4139","LFCR","BK4212","CFO"],"gpt_icon":0},{"id":"2578959887","title":"Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2578959887","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578959887?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:00","pubTimestamp":1761649200,"startTime":"0","endTime":"0","summary":"CHASKA, Minn. and TORRANCE, Calif., Oct.  28, 2025  (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175225/23089/en/Lifecore-and-PolyPeptide-Announce-Collaboration-Intended-to-Offer-End-to-End-Peptide-Manufacturing-Solution-for-U-S-Market.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDMO","BK4212","LFCR","CFO","BK4139"],"gpt_icon":0},{"id":"2578557605","title":"Elon Musk Loses Another Top Executive As X's Ad Chief Reportedly Quits","url":"https://stock-news.laohu8.com/highlight/detail?id=2578557605","media":"Benzinga_recent_news","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578557605?lang=en_us&edition=fundamental","pubTime":"2025-10-25 15:00","pubTimestamp":1761375600,"startTime":"0","endTime":"0","summary":"John Nitti, who served as global head of revenue operations and advertising innovation at X, has left the social media company after just 10 months in the role, according to a report by the Financial Times on Friday.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/25/Twitter-Logo-After-Renaming-The-Company-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/25/Twitter-Logo-After-Renaming-The-Company-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/tech/25/10/48421431/elon-musk-loses-another-top-executive-as-xs-ad-chief-reportedly-quits","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/tech/25/10/48421431/elon-musk-loses-another-top-executive-as-xs-ad-chief-reportedly-quits","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["CFO","LU2168564149.EUR","SHEL","LU0061474705.USD","LU1221951046.USD","LU0985489474.SGD","PINS","SG9999002224.SGD","BK4551","IE00BN29S564.USD","LU2471134952.CNY","DXYZ","LU1674673428.USD","BK4555","BK4127","BK4579","SG9999018857.SGD","LU1804176565.USD","LU1989764748.USD","IE00B19Z3581.USD","LU0444973449.USD","USJW.SI","LU2125154778.USD","LU0494093205.USD","LU2098885051.SGD","SG9999014898.SGD","LU1934455194.USD","LU1668664300.SGD","BK4574","LU1852331112.SGD","BK4527","LU0175139822.USD","LU0208291251.USD","LU1162221912.USD","LU2471134879.HKD","LU2552382215.SGD","LU0130518102.USD","TSYW.SI","LU1629891620.HKD","LU0648000940.SGD","LU1280957306.USD","UFO","LU2028103732.USD","LU1363072403.SGD","LU1989764664.SGD","LU1037948897.HKD"],"gpt_icon":1},{"id":"2576543071","title":"Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2576543071","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576543071?lang=en_us&edition=fundamental","pubTime":"2025-10-19 22:00","pubTimestamp":1760882400,"startTime":"0","endTime":"0","summary":"Median progression free survival (PFS) has not been reached in the cohort of patients with salivary gland cancer with PFS follow up suggesting a more than doubling of the benchmark PFS and a disease c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/19/3169020/0/en/Avacta-Therapeutics-Presents-Compelling-Phase-1a-Data-for-Faridoxorubicin-and-the-pre-CISION-Platform-at-the-European-Society-of-Medical-Oncology-Annual-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG0V08.USD","BK4165","IE00BYQNZ168.SGD","AR","BK4139","BK4213","LU2039709279.SGD","BK4571","BK4548","LU0347712357.USD","CEO","BK4531","BK4211","BK4563","BK4552","LU1093756325.SGD","LU1093756168.USD","LENZ","BK4535","BK4131","TME","01698","BK4007","BK4588","LU1721428933.USD","LU0456842615.SGD","LU2211817866.USD","LU2413666426.HKD","BK4195","BK4565","BK4108","SG9999011746.SGD","ECHO","CFO","IE00BYQQ9H92.USD","LU0359201612.USD","IE00B12V2V27.USD","LU0359202008.SGD","BK4567","BK4121","BK4526","ADT","LU2413666699.HKD","MTD","LU1023057109.AUD","BK4509","BK4539","BK4585","BK4192","PFS"],"gpt_icon":0},{"id":"2576778172","title":"Press Release: I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2576778172","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576778172?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:05","pubTimestamp":1760645100,"startTime":"0","endTime":"0","summary":"-- New business model reflects strategic transition to a global biotech. platform focused on business development and translational clinical. development to accelerate access to innovative medicines for patients. -- Intention to pursue a Hong Kong initial public offering  to expand. access to global capital and innovation through dual listing on NASDAQ. -- Name change to be effective following shareholder approval, which is. expected at the Extraordinary General Meeting  on October 24, 2025. potent molecule that could potentially provide more effective and durable. treatment benefits for patients with wet AMD and DME than current. standard of care. The pending acquisition will be completed by a newly. Mr. Kyler Lei has been named Chief Financial Officer  of I-Mab, bringing significant expertise in the Hong Kong and global capital markets.The Company sees a significant growth potential from the Asia Pacific originated biopharma innovations. Confidence in this opportunity comes from emer","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348814723.USD","USJW.SI","00388","LU0516422952.EUR","LU0488056044.USD","SQQQ","LU0642271901.SGD","BK4614","LU0251144936.SGD","LU1105468828.SGD","LU0164880469.USD","IE00BZ08YS42.EUR","80388","LU1852331112.SGD","CEO","SG9999001093.SGD","LU1048588211.SGD","LU0043850808.USD","NQmain","PSQ","LU0370786039.SGD","LU0708995583.HKD","PFS","USAW.SI","LU0577902454.USD","TSYW.SI","IMAB","IE00B5949003.HKD","LU0348816934.USD","LU0052750758.USD","LU2250418816.HKD","LU0540923850.HKD","CFO",".IXIC","LU1880398471.USD","LU1807302812.USD","LU0955623706.USD","TQQQ","LU1282649810.SGD","NVIW.SI","QLD","QID","LU0516422440.USD","IPO","HKXCY","HEXmain","MNQmain","BK4532"],"gpt_icon":1},{"id":"2575749392","title":"Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2575749392","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575749392?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:30","pubTimestamp":1760617800,"startTime":"0","endTime":"0","summary":"Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experienceVANCOUVER, British Columbia and BOSTON, Oct.  16, 2025  (GLOBE NEWSWIRE) -- Xenon","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/16/3167905/33485/en/Xenon-Announces-Appointment-of-Tucker-Kelly-as-Chief-Financial-Officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO"],"gpt_icon":0},{"id":"2575971922","title":"Press Release: Fate Therapeutics Expands Leadership Team with Appointment of Kamal Adawi as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2575971922","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575971922?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:00","pubTimestamp":1760443200,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Oct. 14, 2025  -- Fate Therapeutics, Inc.  , a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell -derived off-the-shelf cellular immunotherapies to patients, today announced the appointment of Kamal Adawi, M.S., M.B.A., to the role of Chief Financial Officer  effective October 20, 2025. Mr. Adawi brings to the Company more than 20 years of financial leadership experience in the life sciences industry, including over 10 years serving as CFO across innovative life science companies, with deep domain expertise in autoimmune diseases, including lupus.\"I am thrilled to join Fate Therapeutics at such an exciting time, as the Company paves the path for its registrational trial of FT819 in SLE, \" said Mr. Adawi. \"Fate's approach to developing off-the-shelf cellular immunotherapies, designed to be broadly accessible with less intensive or no conditioning chemotherapy, is highly differentiated and has the potential to meaningful","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4120","CFO","BK4139","FATE","TISI"],"gpt_icon":0},{"id":"2575404270","title":"Switzer Investing TV | 13 Oct 2025: Super Tax changes incoming | Trump v China, Part II | Busting Australian property myths","url":"https://stock-news.laohu8.com/highlight/detail?id=2575404270","media":"Switzer","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575404270?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:43","pubTimestamp":1760359430,"startTime":"0","endTime":"0","summary":"Peter Switzer is joined by three expert guests to unpack the biggest stories shaping markets, property and innovation this week.","market":"hk","thumbnail":"https://switzer.com.au/wp-content/uploads/STV-Thumbnail-3.png","type":0,"news_type":0,"thumbnails":["https://switzer.com.au/wp-content/uploads/STV-Thumbnail-3.png"],"rights":{"source":"switzer_stock","url":"https://switzer.com.au/the-experts/luke-hopewell/switzer-investing-tv-13-oct-2025-super-tax-changes-incoming-trump-v-china-part-ii-busting-australian-property-myths/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://switzer.com.au/the-experts/luke-hopewell/switzer-investing-tv-13-oct-2025-super-tax-changes-incoming-trump-v-china-part-ii-busting-australian-property-myths/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"switzer_stock","symbols":["CFO","CFO.AU","CEO","XJO.AU","XAO.AU","BK7023","TV","BK7007","XKO.AU","CMP.AU","BK4100"],"gpt_icon":0},{"id":"2575707984","title":"Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2575707984","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575707984?lang=en_us&edition=fundamental","pubTime":"2025-10-13 19:00","pubTimestamp":1760353200,"startTime":"0","endTime":"0","summary":"Vida Strategic Partners. Stephanie Diaz (Investors). 415-675-7401. sdiaz@vidasp.com. Tim Brons (Media). 415-675-7402. tbrons@vidasp.com. Ryan D. Lake (CFO). 952-368-6244. ryan.lake@lifecore.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/13/3165425/23089/en/Lifecore-Biomedical-to-Participate-at-Upcoming-Industry-Conferences-and-Events.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1119994496.HKD","LU2065169927.USD","BK4585","BK4082","LU1261432733.SGD","CDMO","LU0728928796.USD","BK4551","BK4121","CFO","LU1084165304.USD","LU2065171402.SGD","PODD","LU2065171311.SGD","LFCR","BK4588","BK4139","BK4212","LU2324357040.USD","BK4566","LU2065170008.USD"],"gpt_icon":0},{"id":"2575424108","title":"Cornish Metals Announces Exercise of Stock Options and Issue of Equity & PDMR Dealings","url":"https://stock-news.laohu8.com/highlight/detail?id=2575424108","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575424108?lang=en_us&edition=fundamental","pubTime":"2025-10-13 14:01","pubTimestamp":1760335260,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, Oct.  13, 2025  (GLOBE NEWSWIRE) -- Cornish Metals Inc. (AIM/TSXV: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on adva","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/13/3165293/0/en/Cornish-Metals-Announces-Exercise-of-Stock-Options-and-Issue-of-Equity-PDMR-Dealings.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQR","IE00BD0PCF45.HKD","MAR","IE00B95QR487.USD","BK4585","IE00B1G9WX41.USD","LU1718418525.SGD","BK4142","BK4588","IE00B0T0GQ85.USD","IE00B45NX917.SGD","CFO","BK4215"],"gpt_icon":0},{"id":"2574191823","title":"Press Release: CompoSecure Appoints Mary Holt as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2574191823","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574191823?lang=en_us&edition=fundamental","pubTime":"2025-10-10 04:15","pubTimestamp":1760040900,"startTime":"0","endTime":"0","summary":"SOMERSET, N.J., Oct. 09, 2025  -- CompoSecure, Inc. , a leader in metal payment cards, security, and authentication solutions, today announced the appointment of Mary Holt as Chief Financial Officer , effective the day immediately following the filing of the Company's Q3 2025 Quarterly Report. She succeeds Tim Fitzsimmons who is retiring after a distinguished career with the company. As CFO, Ms. Holt will oversee CompoSecure's finance organization, including financial planning and analysis; accounting and financial reporting; treasury and cash management; risk management and compliance; and investor relations. She will report directly to Jon Wilk, President and Chief Executive Officer of CompoSecure.Founded in 2000, CompoSecure  is a technology partner to market leaders, fintechs and consumers enabling trust for millions of people around the globe. The Company combines elegance, simplicity and security to deliver exceptional experiences and peace of min","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO","CMPO","BK4170"],"gpt_icon":0},{"id":"1184639010","title":"PepsiCo Reports Strong Third Quarter Revenue Despite Weakening North American Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1184639010","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184639010?lang=en_us&edition=fundamental","pubTime":"2025-10-09 19:49","pubTimestamp":1760010570,"startTime":"0","endTime":"0","summary":"Despite softer demand for snacks and beverages in North America, PepsiCo delivered third-quarter revenue that exceeded analyst expectations. For the quarter spanning July through September, PepsiCo's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFO"],"gpt_icon":0},{"id":"2573391024","title":"What's Behind AlphaTON Capital's 123% After-Hours Spike?","url":"https://stock-news.laohu8.com/highlight/detail?id=2573391024","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573391024?lang=en_us&edition=fundamental","pubTime":"2025-10-08 14:50","pubTimestamp":1759906200,"startTime":"0","endTime":"0","summary":"AlphaTON Capital Corp (NASDAQ:ATON) shares surged in after-hours trading on Tuesday, jumping 123.12% from the regular session close of $5.58 to $12.45. This $6.87 rise more than doubled the stock's price after the market closed.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/08/Business-Development--Financial-Plan-And.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/08/Business-Development--Financial-Plan-And.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/equities/25/10/48093176/whats-behind-alphaton-capitals-123-after-hours-spike","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/10/48093176/whats-behind-alphaton-capitals-123-after-hours-spike","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["CFO","ATON","BK4139"],"gpt_icon":0},{"id":"2572568254","title":"Why Planet Labs Stock Is Skyrocketing This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2572568254","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572568254?lang=en_us&edition=fundamental","pubTime":"2025-10-04 01:30","pubTimestamp":1759512600,"startTime":"0","endTime":"0","summary":"Planet Labs' satellite constellation is growing, its backlog is booming, its cash flows are positive, and its share price is rising.","market":"fut","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F836262%2Fgettyimages-1391594880.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F836262%2Fgettyimages-1391594880.jpg&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/investing/2025/10/03/why-planet-labs-stock-is-skyrocketing-this-week/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/10/03/why-planet-labs-stock-is-skyrocketing-this-week/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["CFO"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":76,"code":"91000000","status":"200"}]}}